Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: FLARE

Systemic Juvenile Idiopathic Arthritis

Rayfel Schneider, MBBCh, and Ronald M. Laxer, MDCM  |  May 9, 2012

Changing treatment paradigms in the biologic era

Filed under:Clinical Criteria/GuidelinesConditionsRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatorydrugJIAJuvenile idiopathic arthritismacrophage activation syndromeMethotrexatepatient carePediatricsrheumatologistSteroidstocilizumabTreatment

ACR/ARHP Annual Scientific Meeting Plenary Highlights Targets and Treatments for Several Diseases

Vanessa Caceres  |  April 6, 2012

Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid ArthritisSystemic SclerosisVasculitis Tagged with:ACR/ARHP Annual MeetingJAK inhibitorsjanus kinaseRAResearchRheumatoid arthritisrituximabSclerodermasclerosisTreatmentVasculitis

A Patient’s Perspective on RA

Lisa C. Glavish  |  February 3, 2012

I was diagnosed in April 2010, at 44 years old, with seropositive RA; the disease rapidly turned my life upside down.

Filed under:ConditionsPatient PerspectivePractice SupportProfilesRheumatoid Arthritis Tagged with:drugMethotrexatePainpatient carePatientsprednisoneProfileRARheumatoid arthritisrheumatologist

Coding Corner: February’s Coding Challenge

Staff  |  February 3, 2012

A 62-year-old male patient returns to the office for a followup visit for his gout.

Filed under:Billing/CodingConditionsGout and Crystalline ArthritisPractice Support Tagged with:BillingCancerCodingcrystal arthritisE&MGoutlabsPractice Managementrheumatologist

A Short History of Rheumatoid Arthritis Therapeutics

Simon M. Helfgott, MD  |  January 13, 2012

Or, why I chose to become a rheumatologist

Filed under:Biologics/DMARDsConditionsDrug UpdatesOpinionProfilesResearch RheumRheumatoid ArthritisRheuminationsSpeak Out Rheum Tagged with:BiologicsdrugEducationHelfgottMethotrexateprednisoneProfileResearchresidencyRheumatoid arthritisrheumatologist

Drug Updates: Apremilast, Belimumab, and More

Michele B. Kaufman, PharmD, BCGP  |  January 13, 2012

Information on new approvals and medication safety

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisSystemic Lupus Erythematosus Tagged with:Ankylosing Spondylitisanti-inflammatoryApprovalsBiologicsdrugJAK inhibitorsjanus kinaseMethotrexatePipelinePsoriatic ArthritisSafetySystemic lupus erythematosus

A Celebration of Accomplishments

Richard Quinn  |  December 12, 2011

ARHP recognizes health professionals for their contributions to the field

Filed under:AwardsProfessional Topics Tagged with:2011 ACR/ARHP Annual Scientific MeetingAC&RAssociation of Rheumatology Professionals (ARP)Awards

A Window into Health Disparities

Edward H. Yelin, PhD, MCP  |  October 7, 2011

Systemic lupus erythematosus offers a touchstone for the U.S. healthcare system–and how we care for vulnerable patients

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:DisparitiesethnicityLupuspatient careraceSLE

Plan Now for ICD-10 Changeover

Kurt Ullman  |  May 16, 2011

Coding changes will have an impact on staff, physicians, and even the finances of rheumatology practices

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingICD-10ICD-9physicianPractice ManagementReimbursement

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  May 16, 2011

Information on New Approvals and Medication Safety

Filed under:AnalgesicsDrug Updates Tagged with:ApprovalsDrugsFDAPipelineSafetyshortage

  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 68
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences